ACYTE Biotech Information

ACYTE Biotech supplies proprietary mammalian cell lines and technologies to enhance cell engineering and culture processes to streamline biologics development from discovery to clinic. ACYTE provides biotech companies adaptable, stable and robust cell lines with superior growth performance for expression of monoclonal antibodies, fusion proteins, antibody fragments, recombinant proteins, etc. ACYTE’s suite of SuperCHO® technologies span stable and transient cell lines, antibody vectors and clonal isolation processes.

Website	http://www.acyte.com
Revenue	$8.9 million
Employees	2 (1 on RocketReach)
Founded	2003
Address	Rupert Myers Bldg Barker St, Sydney, New South Wales 2052, AU
Phone	+61 7 3346 3975
Technologies	JavaScript , PHP , Nginx +3 more (view full list)
Industry	Biotechnology Research, Business Services General, Business Services
Keywords	Biologics Development, Cell Lines, Cell Engineering, Biologics Manufacturing, Biopharmaceutical Development, Biopharmaceutical Manufacturing, Cell Culture, Bioprocessing, Cell Technology, Upstream Processing, Therapeutic Proteins, Cell Line Development, Process Development, Drug Discovery, Cell Culture Media, Biotechnology
Competitors	Thermo Fisher Scientific, Agilent Technologies, Bioventus, Cepheid, BD, Illumina, PerkinElmer, Inc., Merck Group, Roche, GE HealthCare +40 more (view full list)
SIC	SIC Code 87 Companies, SIC Code 873 Companies
NAICS	NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 541713 Companies, NAICS Code 54 Companies